病态造血形态学特征与血液系统疾病相关性研究进展
PDF下载 (418)彭 澄 1,李俊勋 2,欧阳涓 2*.病态造血形态学特征与血液系统疾病相关性研究进展[J].宁波大学学报(理工版),2014,27(04):108-114.DOI:
PENG Cheng 1,LI Jun-xun 2,OUYANG Juan 2*.Relationship Between Morphological Features of Dyshaematopoiesis and Hematological Diseases: Research Progresses[J].Journal of Ningbo University(Natural Science & Engineering Edition),2014,27(04):108-114.DOI:
| Title: | Relationship Between Morphological Features of Dyshaematopoiesis and Hematological Diseases: Research Progresses |
| 作者: | 彭 澄 1, 李俊勋 2, 欧阳涓 2* |
| Author(s): | PENG Cheng 1, LI Jun-xun 2, OUYANG Juan 2* |
| 关键词: | 病态造血; 骨髓增生异常综合征; 形态学 |
| Keywords: | dyshaematopoiesis; myelodysplastic syndrome; morphology |
| 分类号: | R551.3 |
| 文献标识码: | A |
| 摘要: | 以临床关于骨髓增生异常综合征(MDS)诊断的困惑为出发点, 对各种病态造血的形态学特征进行了系统的整理, 并将其针对不同血液系统疾病的诊断价值和预后评估作用作了全面的总结, 以期为临床上凭借病态造血形态学诊断、分析和评估疾病预后提供参考. |
| Abstract: | This review is conducted on the basis of perplexity of myelodysplastic syndrome (MDS)’s clinical diagnosis. It summarizes the morphological features of all types of dyshaematopoiesis systematically, and comes to a comprehensive conclusion about the diagnostic and prognostic value of dyshaematopoiesis for different hematological diseases. It is expected to help the doctors to diagnose, analyze and evaluate the prognosis of disease using the morphology of dyshaematopoiesis. |
| 参考文献 /References: | [1] 岳兰竹, 宗鸿. 髓增生异常综合征诊断研究进展—–维也纳诊断标准及2008 WHO诊断标准解读[J]. 国际输血及血液学杂志, 2010, 33(3):195-197. [2] Parmentier S, Schetelig J, Lorenz K, et al. Assessment of dysplastic hematopoiesis: Lessons from healthy bone marrow donors[J]. Haematologica, 2012, 97(5):723-730. [3] Germing U, Strupp C, Giagounidis A, et al. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Dusseldorf registry on myelodysplastic syndromes[J]. Leuk Res, 2012, 36(6):727-734. [4] Liu D, Chen Z, Xue Y, et al. The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients[J]. Leuk Res, 2009, 33(8):1029-1038. [5] Yashige H, Horiike S, Taniwaki M, et al. Micronuclei and nuclear abnormalities observed in erythroblasts in myelo- dysplastic syndromes and in de novo acute leukemia after treatment[J]. Acta Haematol, 1999, 101:32-40. [6] Kuriyama K, Tomonaga M, Matsuo T, et al. Diagnostic significance of detecting Pseudo-Pelger-Huet anomalies and micro-megakaryocytes in myelodysplastic syndrome [J]. Br J Haematol, 1986, 63(4):665-669. [7] Lasho T L, Finke C M, Hanson C A, et al. SF3B1 mutations in primary myelo?brosis: Clinical, histopath- ology and genetic correlates among 155 patients[J]. Leukemia, 2012, 26(5):1135-1137. [8] Malcovati L, Della P M G, Pietra D, et al. Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis[J]. Blood, 2009, 114(17):3538-3545. [9] Patnaik M M, Hanson C A, Sulai N H, et al. Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts[J]. Blood, 2012, 119(24):5674. [10] 姬美容, 陈波斌, 许小平, 等. 骨髓增生异常综合征345例病态造血特点分析[J]. 白血病? 淋巴瘤, 2009(7): 402-406. [11] 伍柏青, 陈世林, 张水生. 112例骨髓增生异常综合征FAB和WHO分型细胞形态学观察[J]. 检验医学, 2010, 25(8):612-614. [12] Tassin F, Dewé W, Schaaf N, et al. A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes[J]. Leuk Lymphoma, 2000, 36(5/6):485-496. [13] Matsuda A, Jinnai I, Yagasaki F, et al. New system for assessing the prognosis of refractory anemia patients[J]. Leukemia, 1999, 13(11):1727-1734. [14] Tennant G B, Cavill I, Burnett A K. Long-term survival of myelodysplastic patients with macrocytosis[J]. Br J Haematol, 2004, 124(6):840-841. [15] Gattermann N, Aul C, Schneider W. Two types of acquired idiopathic sideroblastic anaemia (AISA)[J]. Br J Haematol, 1990, 74(1):45-52. [16] Cazzola M, Invernizzi R. Ring sideroblasts and sideroblastic anemias[J]. Haematologica, 2011, 96(6): 789-792. [17] 朱士红, 王永志, 朱理平. 缺铁性贫血骨髓巨核细胞的变化[J]. 临床医学, 2011, 11(31):28. [18] 唐艺, 熊国干. MCV、RDW在骨髓增生异常综合征和缺铁性贫血鉴别诊断中的应用价值[J].实用医技杂志, 2007, 14(34):4690-4691. [19] 许文荣, 王建中. 临床血液学与检验[M]. 4版. 北京: 人民卫生出版社, 2008:184-189. [20] 王丽, 金瑄. 60例巨幼细胞性贫血患者的细胞形态学分析[J]. 国际检验医学杂志, 2011, 14:1636-1637. [21] 贺姝慧, 张庆勇. 血红细胞形态结合红细胞参数在初诊恶性贫血与巨幼红细胞性贫血中的应用[J]. 广东医学, 2012, 33(2):298. [22] 李静, 卢艳, 李志琴. 骨髓小粒对MDS诊断及与非典型再障、增生性贫血的鉴别诊断意义[J]. 长春中医药大学学报, 2009, 25(6):925-926. [23] Bain B J. The bone marrow aspirate of healthy subjects[J]. Br J Haematol, 1996, 94(1):206-209. [24] Parmentier S, Schetelig J, Lorenz K, et al. Assessment of dysplastic hematopoiesis: Lessons from healthy bone marrow donors[J]. Haematologica, 2012, 97(5):723-730. [25] Amos R J, Deane M, Ferguson C, et al. Observations on the haemopoietic response to critical illness[J]. J Clin Pathol, 1990, 43(10):850-856. [26] Dawson M A, Deane M, Ferguson C, et al. Linezolid- induced dyserythropoiesis: Chloramphenicol toxicity revisited[J]. Intern Med J, 2005, 35(10):626-628. [27] Westhoff D D, Samaha R J, Barnes A J. Arsenic intoxication as a cause of megaloblastic anemia[J]. Blood, 1975, 45(2):241-246. [28] Pye K G, Kelsey S M, House I M, et al. Severe dyserythropoiesis and autoimmune thrombocytopenia associated with ingestion of kelp supplements[J]. Lancet, 1992, 339(8808):1540. [29] Gregg X T, Reddy V, Prchal J T. Copper deficiency masquerading as myelodysplastic syndrome[J]. Blood, 2002, 100(4):1493-1495. [30] Huff J D, Keung Y K, Thakuri M, et al. Copper deficiency causes reversible myelodysplasia[J]. Am J Hematol, 2007, 82(7):625-630. [31] Carpenter S L, Zimmerman S A, Ware R E. Acute parvovirus B19 infection mimicking congenital dyserythropoietic anemia[J]. J Pediatr Hematol Oncol, 2004, 26(2):133-135. [32] Michot F, Gut J. Alcohol-induced bone marrow damage: A bone marrow study in alcohol-dependent individuals[J]. Acta Haematol, 1987, 78(4):252-257. [33] Ballard H S. Alcohol-associated pancytopenia with hypocellular bone marrow[J]. Am J Clin Pathol, 1980, 73(6):830-834. [34] Hadnagy C, Laszlo G A. Acquired dyserythropoiesis in liver disease[J]. Br J Haematol, 1991, 78(2):283. [35] Karcher D S, Frost A R. The bone marrow in human immunodeficiency virus (HIV)-related disease[J]. Morphology and Clinical Correlation Am J Clin Pathol, 1991, 95(1):63-71. [36] Vives-Corrons J L, Briggs C, Simon-Lopez R, et al. Effect of EDTA-anticoagulated whole blood storage on cell morphology examination: A need for standardization [J]. Int J Lab Hematol, 2014, 36(2):222-226. [37] Lee S H, Erber W N, Porwit A, et al. ICSH guidelines for the standardization of bone marrow specimens and reports[J]. Int J Lab Hematol, 2008, 30(5):349-364. [38] 刘丹丹, 吴德沛. 骨髓增生异常综合征诊治新进展—–细胞形态学检查诊断骨髓增生异常综合征临床意义[J]. 中国实用内科杂志, 2010(5):398-401. [39] 张俊. 骨髓增生异常综合征病态造血细胞克隆起源的FISH研究[J]. 中华血液学杂志, 2009(5):332-334. |
| 备注/Memo: | 收稿日期: 2013-05-15. 宁波大学学报（理工版）网址: http://journallg.nbu.edu.cn/基金项目: 国家自然科学基金青年科学基金（81101316）.第一作者: 彭澄（1991－）, 女, 陕西西安人, 在读硕士研究生, 主要研究方向: 血液疾病诊断. E-mail: 13430357145@139.com*通信作者: 欧阳涓（1972－）, 女, 湖北武汉人, 博士/副主任技师, 主要研究方向: 血液疾病诊断. E-mail: Rfouyang@tom.com 宁波大学学报（理工版）网址：http://journallg.nbu.edu.cn/ |
